Skip to content
10-Q

Quarterly Report

EMRISE CORP

0001493152-15-002040

← back to feed
Filed
May 15, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · May 15, 2015 10.82M sh
Shares Diluted Q1 2015 · Mar 31, 2015 10.81K sh
Shares Diluted Q1 2015 · Mar 31, 2014 10.72K sh
Operating Cash Flow Q1 2015 · Mar 31, 2015 $445K
Operating Cash Flow Q1 2015 · Mar 31, 2014 −$118K
Cash And Equivalents Q1 2015 · Mar 31, 2015 $1.68M
Cash And Equivalents Q1 2015 · Dec 31, 2014 $2.36M
Cash And Equivalents Q1 2015 · Mar 31, 2014 $2.69M
Cash And Equivalents Q1 2015 · Dec 31, 2013 $1.17M
Stockholders Equity Q1 2015 · Mar 31, 2015 $9.96M
Stockholders Equity Q1 2015 · Dec 31, 2014 $11.04M
Current Liabilities Q1 2015 · Mar 31, 2015 $9.58M
Current Liabilities Q1 2015 · Dec 31, 2014 $9.81M
Total Liabilities Q1 2015 · Mar 31, 2015 $13.17M
Total Liabilities Q1 2015 · Dec 31, 2014 $13.81M
Current Assets Q1 2015 · Mar 31, 2015 $13.82M
Current Assets Q1 2015 · Dec 31, 2014 $15M
Total Assets Q1 2015 · Mar 31, 2015 $23.13M
Total Assets Q1 2015 · Dec 31, 2014 $24.86M
Sga Expense Q1 2015 · Mar 31, 2015 −$694K
Sga Expense restated Q1 2015 · Mar 31, 2014 −$780K
Net Income Q1 2015 · Mar 31, 2015 −$176K
Net Income Q1 2015 · Mar 31, 2014 −$785K